Literature DB >> 7379446

Renal tubular secretion and effects of furosemide.

B Odlind, B Beermann.   

Abstract

Continuous intravenous infusion of furosemide (8 mg/hr) to 6 healthy subjects induced an average diuresis at steady state of 667 +/- 144 ml/30 min (+/- SD) with a mean plasma concentration of furosemide of 623 +/- 209 ng/ml. The urinary output of Cl- was 50.4 +/- 7.5, of Na+ 47.7 +/- 8.7, and of K+ 5.4 +/- 0.6 mmole/30 min. Intravenous injection of probenecid (1 gm) raised the plasma furosemide level to a maximum of 1,584 +/- 151 ng/ml. Despite this, the urinary excretion of water, Cl-, Na+, and K+ decreased to 52%, 39%, 39%, and 52%, respectively, of control values. Probenecid greatly reduced the urinary excretion and renal clearance of furosemide. There was no or negative correlation between the plasma levels of furosemide and its diuretic and saluretic effects. The urinary excretion and renal clearance of the diuretic correlated positively with these effects. No effect of probenecid on protein binding of furosemide was detected. The findings show that the diuretic effects of furosemide depend on active tubular secretion of the drug and thus on its tubular fluid concentration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379446     DOI: 10.1038/clpt.1980.111

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  28 in total

1.  The influence of drug input rate on the development of tolerance to frusemide.

Authors:  M Wakelkamp; G Alván; H Scheinin; J Gabrielsson
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

2.  The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide.

Authors:  M Wakelkamp; G Alván; G Paintaud
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

Review 3.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

4.  Perinatal growth restriction decreases diuretic action of furosemide in adult rats.

Authors:  Barent N DuBois; Jacob Pearson; Tahir Mahmood; Duc Nguyen; Kent Thornburg; Ganesh Cherala
Journal:  Eur J Pharmacol       Date:  2014-02-05       Impact factor: 4.432

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 6.  Resistance to loop diuretics. Why it happens and what to do about it.

Authors:  D C Brater
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

7.  Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration.

Authors:  P A Sjöström; B G Kron; B G Odlind
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  High doses of furosemide in children with acute renal failure. A preliminary retrospective study.

Authors:  J Prandota
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 9.  Influence of drug formulation on drug concentration-effect relationships.

Authors:  G Castañeda-Hernández; G Caillé; P du Souich
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

10.  The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.

Authors:  A Fujimura; H Kajiyama; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.